Young athlete died after receiving AstraZeneca vaccine

A young man of 27, athletic and in good health, He died after applying the coronavirus vaccine developed by the AstraZeneca laboratory and the University of Oxford.

The young Englishman had received the Oxford / AstraZeneca against the coronavirus and died a few days after inoculation. This is Jack Last, a 27-year-old engineer who died in 20 days after being vaccinated.

The man, who enjoyed sports as part of his daily life, had been admitted to Addenbrooke’s Hospital in Cambridge for a very specific symptom: he said he suffered from constant headaches of great intensity.

His family said: “The only thing we know is that when he got the WhatsApp message to introduce himself, he never doubted it, but he wondered why it touched him. However, it was because he did not want to make scandals, it was not his nature ”.

Jack Last was 27 and had received the AstraZeneca vaccine

The younger man’s sister spoke to local media and gave more information about her brother’s case: “Jack was transferred to Addenbrooke Hospital from West Suffolk on April 11, when he started having a bleeding in the brain. We are waiting for the results of the autopsy to be confirmed, but we believe his death was related to the vaccine”.

From the Suffolk Integrated Care System and North East Essex, they posted a message in which they mourned the young man’s death. “We were deeply saddened learn of Jack’s death and our hearts go out to his loved ones, with whom we remain in contact as we fully investigate the circumstances surrounding his death, ”they said from the institution.

What was Jack Last’s life like before he got the shot?

According to his family, prior to receiving the vaccine, Jack lived in Dagworth with his parents and sister. He had enrolled in a college known as Stowupland High School and as an adult he had graduated as an engineer in agricultural service at Claas in Saxham.

In addition, he was licensed to fly airplanes privately and was fond of winter sports such as skiing; he loved to travel to France to hurtle down the slopes of the Gallic country.

The young man had applied the vaccine against the coronavirus developed by AstraZeneca and Oxford

His first job was for Claas in New Zealand, then he went to Antarctica as part of a science project and in 2018 he finally got his American pilot’s license.

AstraZeneca vaccine questions

Currently, there are already over 33.8 million Britons vaccinated with one dose of coronavirus vaccination and 13.2 million have already received both doses.

This vaccine has had several problems due to the supposed predisposition to the appearance of clots after its application. Many countries suspended its request and indicated that some people had suffered from the disorder.

There have been concerns about possible serious, but rare, side effects in people vaccinated with AstraZeneca for several weeks.

These would be cases of atypical thrombosis and some of them caused death.

In the UK, there have been 30 cases and seven deaths out of a total of 18.1 million doses administered as of March 24.

For AstraZeneca, benefits of laboratory antidote The Anglo-Swedes in the prevention of Covid-19 outweigh the risks of side effects.

The group said on Saturday that “patient safety” was its “top priority”.

Last month, the EMA itself said the vaccine was “safe and effective,” but would continue to investigate its possible link to side effects.

I change my name

AstraZeneca He has made a firm decision on his coronavirus vaccine. The company has announced that it will change the name of its vaccine after the crisis that has been triggered over its possible Side effects.

To resolve the bad image that has been associated with its name, despite the support that the European Medicines Agency has given to its medicine, the company has decided to change its trademark to end the discredit of its vaccine, which will now be called Vaxzevria.

The change aims to end the reputation crisis that had – and still has – its vaccine. It is worth noting that the change only affects the name, as the company will not change its composition somewhat from the original product that had the original name AstraZeneca.

The cases of thrombi detected in some people inoculated with this product strongly influenced the image and the name of the vaccine. For this reason, the managers of the company decided to change its name so as not to continue to “sink” its vaccine in this crisis.

Either way, it is important to note that it is early to check if this decision you have made AstraZeneca works in public opinion, somewhat reluctant to this vaccine despite the efforts of the authorities to give all its credibility to its efficiency and safety.